E

Epizyme Inc
F:EPE

Watchlist Manager
Epizyme Inc
F:EPE
Watchlist
Price: 559 EUR 3.33% Market Closed
Market Cap: 92.2B EUR
Have any thoughts about
Epizyme Inc?
Write Note

Wall Street
Price Targets

EPE Price Targets Summary
Epizyme Inc

There are no price targets for EPE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Epizyme Inc Competitors:
Price Targets
CAPR
Capricor Therapeutics Inc
201% Upside
OCC
Orthocell Ltd
56% Downside
MNKD
MannKind Corp
43% Upside
LGND
Ligand Pharmaceuticals Inc
30% Upside
CCCC
C4 Therapeutics Inc
331% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
33% Upside
CVAC
CureVac NV
163% Upside
MNPR
Monopar Therapeutics Inc
16% Upside

Revenue
Forecast

Revenue Estimate
Epizyme Inc

For the last 8 years the compound annual growth rate for Epizyme Inc's revenue is -7%. The projected CAGR for the next 1 year is 102%.

-7%
Past Growth
102%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Epizyme Inc

Operating Income forecast
is not available for
Epizyme Inc

Net Income
Forecast

Net Income Estimate
Epizyme Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EPE's stock price target?
Not Available

EPE doesn't have any price targets made by Wall Street professionals.

What is Epizyme Inc's Revenue forecast?
Projected CAGR
102%

For the last 8 years the compound annual growth rate for Epizyme Inc's revenue is -7%. The projected CAGR for the next 1 year is 102%.

Back to Top